135 related articles for article (PubMed ID: 4231841)
1. [Pharmacological effects of a new antihypertensive agent with imidazoline structure].
Hoefke W; Kobinger W
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):28-9. PubMed ID: 4231841
[No Abstract] [Full Text] [Related]
2. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
[No Abstract] [Full Text] [Related]
3. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system.
Boissier JR; Giudicelli JF; Fichelle J; Schmitt H; Schmitt H
Eur J Pharmacol; 1968 Mar; 2(5):333-9. PubMed ID: 5663498
[No Abstract] [Full Text] [Related]
4. Mechanisms of the pressor and depressor actions of St 155 (2-(2,6--dichlorophenylamino)-2-imidazoline hydrochloride, Catapres).
Rand MJ; Wilson J
Eur J Pharmacol; 1968 Apr; 3(1):27-33. PubMed ID: 5658985
[No Abstract] [Full Text] [Related]
5. [Central effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
Hukuhara T; Otsuka Y; Takeda R; Sukai F
Arzneimittelforschung; 1968 Sep; 18(9):1147-53. PubMed ID: 5755929
[No Abstract] [Full Text] [Related]
6. [Blood pressure and heart rate of rats after repeated treatment with 2-(2,6-dichlorphenylamino)-2-imidazoline].
Walland A
Arzneimittelforschung; 1968 Jul; 18(7):833-6. PubMed ID: 5755830
[No Abstract] [Full Text] [Related]
7. [Comparative studies on the influencing of adrenergic reactions by ergotamine and dihydroergotamine in different experimental models].
Salzmann R; Pacha W
Helv Physiol Pharmacol Acta; 1968; 26(2):CR 246-8. PubMed ID: 5246840
[No Abstract] [Full Text] [Related]
8. [On the mechanism of action of a new antihypertensive substance with imidazoline structure].
Kobinger W
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(1):48-58. PubMed ID: 4233006
[No Abstract] [Full Text] [Related]
9. Effect of acute administration of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline HBr (MJ 10459-2) or guanethidine on selected sympathetically-mediated responses in the anesthetized dog and cat.
Deitchman D; Gomoll AW; Snyder RW; Preston JE
Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):268-78. PubMed ID: 4441194
[No Abstract] [Full Text] [Related]
10. Inhibition of sympathetic activity following chronic administration of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline (MJ 10459-2).
Deitchman D; Gomoll AW; Snyder RW
Eur J Pharmacol; 1974 Oct; 28(2):257-65. PubMed ID: 4418164
[No Abstract] [Full Text] [Related]
11. On the pharmacology of guanoxan.
Vidal-Beretervide K; Pritsch LE; Trinidad H
Arzneimittelforschung; 1969 Jun; 19(6):947-51. PubMed ID: 4389903
[No Abstract] [Full Text] [Related]
12. [Metabolic effects of Catapres].
Rehbinder D; Deckers W
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(2):162-75. PubMed ID: 4235048
[No Abstract] [Full Text] [Related]
13. Dual adrenergic blockade and epinephrine infusion.
Nash CB
J Pharmacol Exp Ther; 1968 Aug; 162(2):246-53. PubMed ID: 5674105
[No Abstract] [Full Text] [Related]
14. Greater effectiveness of phenoxybenzamine in blocking vasoconstrictor responses to central sympathetic stimulation than to norepinephrine administration in the cat.
Miranda PM; Gómez B
J Pharmacol Exp Ther; 1970 Dec; 175(3):600-8. PubMed ID: 5489917
[No Abstract] [Full Text] [Related]
15. [Mechanism of action of 2-(2,6-dichlorophenylamine)2-imidazoline hydrochloride. Experimental studies in normal animals].
Brugger A; Oliver R; Salvá JA
Rev Esp Fisiol; 1970 Mar; 26(1):1-8. PubMed ID: 5431809
[No Abstract] [Full Text] [Related]
16. [Effect of 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on arterial oxygen tension and blood pressure at rest and during exertion].
Stauch M
Arzneimittelforschung; 1968 May; 18(5):597-600. PubMed ID: 5755890
[No Abstract] [Full Text] [Related]
17. Mechanism of action of ST 155 on the blood-pressure in rats.
Kündig H; Monnier H; Levin NW; Charlton RW
Arzneimittelforschung; 1967 Nov; 17(11):1440-4. PubMed ID: 5632165
[No Abstract] [Full Text] [Related]
18. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
[No Abstract] [Full Text] [Related]
19. Agonist-antagonist interactions in the normal and supersensitive nictitating membrane of the spinal cat.
Green RD; Fleming WW
J Pharmacol Exp Ther; 1967 May; 156(2):207-14. PubMed ID: 6026252
[No Abstract] [Full Text] [Related]
20. An investigation into the bradycardic effects of ST 155 [2-(2,6-dichlorophenylamino)-2-imidazoline HCl] in the anesthetized dog.
Robson RD; Kaplan HR; Laforce S
J Pharmacol Exp Ther; 1969 Sep; 169(1):120-31. PubMed ID: 4389918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
